Previously, elevated LIGHT levels have been measured in some bone diseases, such as rheumatoid arthritis [31], osteolytic multiple myeloma [18], and bone metastatic non-small cell lung cancer (NSCLC) [20]. This evidence concerns the gene TNFSF14 and plasma cell myeloma.